Methods and compositions for modulating the activities of connexins areprovided, including, for example, for use in post-surgical, trauma, or tissueengineering applications. These compounds and methods can be usedtherapeutically, for example, to reduce the severity of adverse effectsassociated diseases and disorders where localized disruption in direct cell-cell communication is desirable.
